Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age-associated memory impairment
Randomized study in people · 1994
- What was studied
- 162 adults aged 55 or older with age-associated memory impairment; 54 per arm; 135 completed
- Main finding
- Three-month randomized, double-blind trial compared two piracetam groups with placebo alongside memory training. Reported benefits depended on baseline performance and training timing.
Completed study · 135 overall; 45 per arm
Reported findings and study design
162 adults aged 55+ randomized into three groups of 54; piracetam 2.4 g, 4.8 g or placebo alongside cognitive training for three months; ten-day placebo washout.
Population or model 162 adults aged 55 or older with age-associated memory impairment; 54 per arm; 135 completed
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Completed study | 135 overall; 45 per arm | |
| Non-completion | 27 overall | Calculated from 162 enrolled minus 135 completed |
| Best reported combination | 4.8 g and training beginning after six weeks | No numerical memory-score effect size in abstract |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Memory training is a co-intervention; this is not a drug-only comparison.
- 27 participants did not complete; reasons and handling require full text.
Source details
Journal article
Europe PMC indexed abstract checked; complete trial methods not reviewed.
Abstract
Sources checked
Citation
Israel L, Melac M, Milinkevitch D, Dubos G. Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age-associated memory impairment International psychogeriatrics
Study source ↗ · DOI 10.1017/s1041610294001729 · Bibliography entry · Link to this summary